VICTORY CAPITAL MANAGEMENT INC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 128 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$16,639,000
-8.4%
3,269,112
+13.9%
0.02%
-5.9%
Q2 2021$18,160,000
-15.2%
2,868,986
+3.6%
0.02%
-22.7%
Q1 2021$21,403,000
+41.0%
2,768,882
+19.5%
0.02%
+29.4%
Q4 2020$15,179,000
-6.0%
2,317,397
-4.5%
0.02%
-19.0%
Q3 2020$16,145,000
-14.9%
2,427,806
+6.6%
0.02%
-19.2%
Q2 2020$18,967,000
-55.4%
2,276,960
-58.9%
0.03%
-27.8%
Q1 2020$42,530,000
+81.9%
5,544,852
+97.1%
0.04%
+28.6%
Q4 2019$23,380,000
+20.8%
2,813,451
+7.3%
0.03%
+12.0%
Q3 2019$19,351,000
-13.2%
2,622,122
+32.0%
0.02%
-44.4%
Q2 2019$22,283,000
+25.2%
1,985,990
+20.0%
0.04%
+12.5%
Q1 2019$17,797,000
+28.1%
1,655,530
+79.9%
0.04%
+14.3%
Q4 2018$13,895,000
-15.6%
920,210
+3.3%
0.04%
+2.9%
Q3 2018$16,472,000
+514.2%
890,400
+658.9%
0.03%
+466.7%
Q2 2018$2,682,000
-24.0%
117,320
-5.4%
0.01%
-25.0%
Q1 2018$3,529,000124,0300.01%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
BVF INC/IL 1,877,148$13,853,0001.46%
Congress Park Capital LLC 167,811$1,238,0001.04%
Perceptive Advisors 3,253,923$24,014,0000.65%
RTW INVESTMENTS, LP 990,463$7,310,0000.44%
Spark Investment Management LLC 337,164$2,488,0000.32%
Exane Asset Management 54,065$399,000,0000.31%
DAFNA Capital Management LLC 100,000$738,0000.28%
HARBOURVEST PARTNERS LLC 79,193$584,0000.24%
WELD CAPITAL MANAGEMENT LLC 86,363$637,0000.12%
GSA CAPITAL PARTNERS LLP 77,997$576,0000.08%
View complete list of CYTOMX THERAPEUTICS INC shareholders